Nicholas Burwick

1.5k total citations
36 papers, 753 citations indexed

About

Nicholas Burwick is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Nicholas Burwick has authored 36 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Nicholas Burwick's work include Multiple Myeloma Research and Treatments (16 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Cancer Treatment and Pharmacology (5 papers). Nicholas Burwick is often cited by papers focused on Multiple Myeloma Research and Treatments (16 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Cancer Treatment and Pharmacology (5 papers). Nicholas Burwick collaborates with scholars based in United States, Italy and France. Nicholas Burwick's co-authors include Sanjai Sharma, Akiko Shimamura, Aldo M. Roccaro, Irene M. Ghobrial, Xavier Leleu, Feda Azab, Bertal H. Aktas, Abdel Kareem Azab, Tomoka Nakamura and Molly Melhem and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nicholas Burwick

35 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Burwick United States 15 393 313 245 173 171 36 753
Jacques Vargaftig France 12 309 0.8× 439 1.4× 249 1.0× 202 1.2× 174 1.0× 23 887
Lisa Kujawski United States 13 313 0.8× 255 0.8× 359 1.5× 189 1.1× 164 1.0× 21 753
Claudiu Cotta United States 16 294 0.7× 182 0.6× 123 0.5× 123 0.7× 133 0.8× 50 638
Sanjiv Modi United States 8 245 0.6× 242 0.8× 183 0.7× 161 0.9× 210 1.2× 11 589
Bryan Ciccarelli United States 13 530 1.3× 316 1.0× 320 1.3× 276 1.6× 264 1.5× 34 1.1k
Chung Hoow Kok Australia 17 338 0.9× 454 1.5× 245 1.0× 74 0.4× 153 0.9× 68 800
Agnès Daudignon France 13 195 0.5× 278 0.9× 375 1.5× 290 1.7× 130 0.8× 38 687
Afua A. Mensah Switzerland 15 638 1.6× 309 1.0× 143 0.6× 177 1.0× 173 1.0× 30 931
Maurizio Affer United States 11 571 1.5× 401 1.3× 92 0.4× 83 0.5× 176 1.0× 22 843
Odile Maarek France 13 352 0.9× 645 2.1× 411 1.7× 159 0.9× 267 1.6× 24 1.0k

Countries citing papers authored by Nicholas Burwick

Since Specialization
Citations

This map shows the geographic impact of Nicholas Burwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Burwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Burwick more than expected).

Fields of papers citing papers by Nicholas Burwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Burwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Burwick. The network helps show where Nicholas Burwick may publish in the future.

Co-authorship network of co-authors of Nicholas Burwick

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Burwick. A scholar is included among the top collaborators of Nicholas Burwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Burwick. Nicholas Burwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costa, Luciano J., Faith E. Davies, Tibor Kovacsovics, et al.. (2021). Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma. Blood Advances. 5(19). 3748–3759. 53 indexed citations
2.
Graf, Solomon A., Nicholas Burwick, Jonathan E. Grim, et al.. (2020). Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience. Blood Research. 55(1). 57–61. 1 indexed citations
3.
Costa, Luciano J., E. Stadtmauer, Faith E. Davies, et al.. (2019). PS1375 UPDATED SAFETY AND EFFICACY FROM A PHASE 2 STUDY OF VENETOCLAX PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA. HemaSphere. 3(S1). 629–629. 2 indexed citations
4.
Burwick, Nicholas & Sanjai Sharma. (2018). Glucocorticoids in multiple myeloma: past, present, and future. Annals of Hematology. 98(1). 19–28. 79 indexed citations
5.
Burwick, Nicholas, et al.. (2018). Association of Monoclonal Gammopathy with Progression to ESKD among US Veterans. Clinical Journal of the American Society of Nephrology. 13(12). 1810–1815. 5 indexed citations
6.
Costa, Luciano J., Edward A. Stadtmauer, Gareth J. Morgan, et al.. (2018). Phase 2 Study of Venetoclax Plus Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 132(Supplement 1). 303–303. 16 indexed citations
7.
Burwick, Nicholas. (2017). Vitamin D and plasma cell dyscrasias: reviewing the significance. Annals of Hematology. 96(8). 1271–1277. 9 indexed citations
8.
Burwick, Nicholas, Pilar de la Puente, Abdel Kareem Azab, et al.. (2017). The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma. Leukemia Research. 55. 23–32. 22 indexed citations
9.
Burwick, Nicholas, Sarah Buckley, Zhao Dong, & Robert E. Richard. (2016). Lymphomatoid granulomatosis associated with azathioprine use for immune-mediated neuropathy. BMJ Case Reports. 2016. bcr2016216930–bcr2016216930.
10.
Linenberger, Michael, Leona Holmberg, Pamela S. Becker, et al.. (2015). Utilization of stored autologous PBSCs to support second autologous transplantation in multiple myeloma patients in the era of novel agent therapy. Bone Marrow Transplantation. 50(5). 663–667. 11 indexed citations
11.
Singer, Jack W., et al.. (2014). A prospective study of lenalidomide monotherapy for relapse after Allo-SCT for multiple myeloma. Bone Marrow Transplantation. 49(4). 492–495. 15 indexed citations
12.
Libby, Edward N., Pamela S. Becker, Nicholas Burwick, et al.. (2014). Panobinostat: a review of trial results and future prospects in multiple myeloma. Expert Review of Hematology. 8(1). 9–18. 38 indexed citations
13.
George, Evan, et al.. (2013). Granulomatous Scleromyxedema. American Journal of Dermatopathology. 37(3). 240–245. 6 indexed citations
14.
Burwick, Nicholas, Akiko Shimamura, & Johnson M. Liu. (2011). Non–Diamond Blackfan Anemia Disorders of Ribosome Function: Shwachman Diamond Syndrome and 5q- Syndrome. Seminars in Hematology. 48(2). 136–143. 35 indexed citations
15.
Ghobrial, Irene M., Xavier Leleu, Abdel Kareem Azab, et al.. (2009). Novel Therapeutic Agents in Waldenström's Macroglobulinemia. Clinical Lymphoma & Myeloma. 9(1). 84–86. 3 indexed citations
16.
Leleu, Xavier, Edie Weller, Aldo M. Roccaro, et al.. (2008). Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia. Leukemia & lymphoma. 49(6). 1104–1107. 37 indexed citations
17.
Roccaro, Aldo M., Antonio Sacco, Changzhong Chen, et al.. (2008). MicroRNA Signature in Waldenstrom Macroglobulinemia. Blood. 112(11). 630–630. 2 indexed citations
18.
Roccaro, Aldo M., Antonio Sacco, Changzhong Chen, et al.. (2008). microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia. Blood. 113(18). 4391–4402. 88 indexed citations
19.
Moreau, Anne‐Sophie, Yasmine Sebti, Alain Duhamel, et al.. (2008). Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia. European Journal Of Haematology. 80(6). 503–509. 4 indexed citations
20.
Azab, Abdel Kareem, Feda Azab, Costas Pitsillides, et al.. (2008). Rho-a and Rac-1 GTPases Play Major and Differential Roles in SDF1α- Induced Cell Adhesion and Chemotaxis in Multiple Myeloma.. Blood. 112(11). 1666–1666. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Vargaftig Breakdown of academic impact, for papers by Lisa Kujawski Breakdown of academic impact, for papers by Claudiu Cotta Breakdown of academic impact, for papers by Sanjiv Modi Breakdown of academic impact, for papers by Bryan Ciccarelli Breakdown of academic impact, for papers by Chung Hoow Kok Breakdown of academic impact, for papers by Agnès Daudignon Breakdown of academic impact, for papers by Afua A. Mensah Breakdown of academic impact, for papers by Maurizio Affer Breakdown of academic impact, for papers by Odile Maarek
Rankless by CCL
2026